BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein

Since first reported in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly acquiring mutations, particularly in the spike protein, that can modulate pathogenicity, transmission and antibody evasion leading to successive waves of COVID19 infections despite an unprecedented...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mohanraj Manangeeswaran, Derek D. C. Ireland, Seth G. Thacker, Ha-Na Lee, Logan Kelley-Baker, Aaron P. Lewkowicz, Paul W. Rothlauf, Marjorie Cornejo Pontelli, Louis-Marie Bloyet, Michael A. Eckhaus, Mirian I. Mendoza, Sean Whelan, Daniela Verthelyi
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-07-01
Col·lecció:	Frontiers in Immunology
Matèries:	SARS-CoV-2 spike protein neurotropism BSL-2 mouse model pseudotyped virus ACE2 transgenic mice
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.919815/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!